OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc. (OKUR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
okur · stock forecast · 2 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$35.00
Consensus
$35.00
+695.5% upside
Low
$35.00
Median: $35 · Last Close: $4.40
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $4.62 | ↑ 5.00% |
1-day model range: $4.58–$4.66. Peak: $4.66 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -50.0% |
| 2028 | $2 | -62.5% |
| 2029 | $1 | -67.2% |
| 2030 | $1 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · OKUR · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-11 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on OnKure Therapeutics, Inc. (OKUR) stock. Of the recent 5 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover OKUR.
Analyst Recommendation Trends
OKUR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↑ 0.0% YoY
Revenue Next Year
$1M
↓ 25.0% YoY
EPS This Year
$-4.56
EPS Next Year
$-2.79
↓ 38.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast OKUR EPS of $-4.56 for the current fiscal year, based on estimates from 4 analysts. The OKUR revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The OKUR stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OKUR price target is $35.00 (+695.5% upside), with an analyst consensus of Buy.
The OKUR short-term stock prediction for tomorrow is $4.62 (+5.00%). The OKUR stock price prediction for 2027 estimates an average of $2. The OKUR stock prediction for 2030 projects a range of $1–$2.
OnKure Therapeutics, Inc. trades on NASDAQ under the ticker OKUR. The OKUR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
OKUR forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month OKUR price target is $35.00, with a high forecast of $35.00 and a low of $35.00. The median price target is shown in the chart above when available. This implies +695.5% potential upside from the current price of $4.40.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.